verified SJR 0,133 · Q4 • database Scopus / SJR indexed

Netherlands · Springer Netherlands

workspace_premium Q4 — Medicine (miscellaneous) lock Subscription

Cancer Treatment and Research

Cancer Treatment and Research is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 68. It has an SJR impact factor of 0,133 and it has a best quartile of Q4. It is published in English. It has an SJR impact factor of 0,133.

ISSN: 0927-3042

Publisher: Springer Netherlands

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,133 Q4

H-index 68

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR

SJR Impact

0,133

H-index

Docs (year)

Docs 3y

154

Total refs

3182

Cites 3y

124

Citable 3y

Cites/Doc 2y

0.9

Ref/Doc

117.85

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bone marrow transplantation for aplastic anemia: Recent advances and comparisons with alternative therapies

Tumor targeting with monoclonal antibody B72.3: Experimental and clinical results

Circulating cells in Hodgkin's disease

Chronic graft-versus-host disease

Chelates and antibodies: Current methods and new directions

Cell motility in breast cancer

Cathepsins D and B in breast cancer

Breast cancer immunology

Bone marrow transplantation: Introduction and overview

Bone marrow transplantation in acute lymphoblastic leukemia

Bone marrow transplantation for solid tumors in pediatrics

Bone marrow transplantation for immunodeficiency and genetic diseases

SHOW MORE ARTICLES

Bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma

Acute graft-versus-host disease

Bone marrow transplantation for acute nonlymphocytic leukemia (ANL)

Bifunctional chelating agents for radiometal-labeled monoclonal antibodies

Antiestrogen-estrogen receptor interactions

Antiestrogen Therapy for Breast Cancer

Antibody targeting: Theoretical considerations

Antibody lymphoscintigraphy

Antibody imaging of endocrine tumors

Anti-antibody enhancement of tumor imaging

Anthracycline resistance

Alkylating agent resistance

FAQs

Cancer Treatment and Research has an SJR of 0,133 (best quartile Q4) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Cancer Treatment and Research is 29%.

Cancer Treatment and Research

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cancer Treatment and Research?

What is the APC / publication cost?

What is the acceptance rate?